questionText: To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with relevant stakeholders on the supply of Liraglutide to the NHS.
answerText: We are aware of global supply issues with glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), which are licensed for treating patients with type 2 diabetes. This includes liraglutide. We have issued guidance in the form of a Medicine Supply Notificat...
heading: Liraglutide